Titre : Membre-4 de la famille-12 des transporteurs de solutés

Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales fréquentes

Termes MeSH sélectionnés :

Endodermal Sinus Tumor
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales les plus fréquentes", "headline": "Membre-4 de la famille-12 des transporteurs de solutés : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Membre-4 de la famille-12 des transporteurs de solutés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-17", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Membre-4 de la famille-12 des transporteurs de solutés" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Symporteurs des ions sodium-potassium-chlorure", "url": "https://questionsmedicales.fr/mesh/D028021", "about": { "@type": "MedicalCondition", "name": "Symporteurs des ions sodium-potassium-chlorure", "code": { "@type": "MedicalCode", "code": "D028021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875" } } }, "about": { "@type": "MedicalCondition", "name": "Membre-4 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 4", "code": { "@type": "MedicalCode", "code": "D064507", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Simon Franz Müller", "url": "https://questionsmedicales.fr/author/Simon%20Franz%20M%C3%BCller", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany." } }, { "@type": "Person", "name": "Joachim Geyer", "url": "https://questionsmedicales.fr/author/Joachim%20Geyer", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany." } }, { "@type": "Person", "name": "Nipaporn Deejai", "url": "https://questionsmedicales.fr/author/Nipaporn%20Deejai", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Choochai Nettuwakul", "url": "https://questionsmedicales.fr/author/Choochai%20Nettuwakul", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Nunghathai Sawasdee", "url": "https://questionsmedicales.fr/author/Nunghathai%20Sawasdee", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparison of clinical characteristics of testicular tumor between children and adult population: a retrospective analysis.", "datePublished": "2024-10-16", "url": "https://questionsmedicales.fr/article/39415133", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12984-2" } }, { "@type": "ScholarlyArticle", "name": "Postoperative recurrence of mixed extragonadal germ cell tumor in the right shoulder: a case report.", "datePublished": "2023-02-20", "url": "https://questionsmedicales.fr/article/36805679", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13000-023-01312-0" } }, { "@type": "ScholarlyArticle", "name": "[Current view on testicular tumors from a developmental biological perspective : Important biomarkers and molecular pathological investigations].", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35925316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00292-022-01094-0" } }, { "@type": "ScholarlyArticle", "name": "Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36502737", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.prp.2022.154269" } }, { "@type": "ScholarlyArticle", "name": "Primary yolk sac tumor of the endometrium combined with situs inversus totalis: a case report and literature review.", "datePublished": "2024-09-03", "url": "https://questionsmedicales.fr/article/39227947", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-024-03327-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Protéines transporteurs de solutés", "item": "https://questionsmedicales.fr/mesh/D000070590" }, { "@type": "ListItem", "position": 7, "name": "Symporteurs des ions sodium-potassium-chlorure", "item": "https://questionsmedicales.fr/mesh/D028021" }, { "@type": "ListItem", "position": 8, "name": "Membre-4 de la famille-12 des transporteurs de solutés", "item": "https://questionsmedicales.fr/mesh/D064507" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Membre-4 de la famille-12 des transporteurs de solutés - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Comment diagnostiquer une dysfonction de SLC12A4 ?\nQuels tests sont utilisés pour évaluer SLC12A4 ?\nY a-t-il des marqueurs spécifiques pour SLC12A4 ?\nLes imageries médicales aident-elles au diagnostic ?\nLe diagnostic nécessite-t-il une biopsie ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels sont les symptômes d'une anomalie de SLC12A4 ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes sont-ils toujours présents ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Comment prévenir les troubles liés à SLC12A4 ?\nY a-t-il des tests de dépistage recommandés ?\nLes conseils génétiques sont-ils utiles ?\nLes vaccinations influencent-elles SLC12A4 ?\nL'exercice physique aide-t-il à prévenir les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels traitements sont disponibles pour SLC12A4 ?\nLa thérapie génique est-elle une option ?\nLes changements alimentaires aident-ils ?\nDes traitements symptomatiques existent-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quelles complications peuvent survenir avec SLC12A4 ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nDes soins palliatifs sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels sont les facteurs de risque pour SLC12A4 ?\nL'environnement influence-t-il SLC12A4 ?\nLe mode de vie joue-t-il un rôle ?\nLes infections augmentent-elles le risque ?\nL'âge est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Endodermal+Sinus+Tumor&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction de SLC12A4 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des analyses biochimiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer SLC12A4 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de transport ionique et des analyses de sang peuvent être effectués." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour SLC12A4 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs spécifiques largement reconnus." } }, { "@type": "Question", "name": "Les imageries médicales aident-elles au diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les imageries peuvent aider à évaluer des anomalies, mais ne sont pas spécifiques." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il une biopsie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie n'est généralement pas nécessaire pour diagnostiquer SLC12A4." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une anomalie de SLC12A4 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des déséquilibres électrolytiques et des troubles neurologiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les signes de déshydratation et de fatigue excessive." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains patients peuvent être asymptomatiques malgré une anomalie." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver avec le temps." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à SLC12A4 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et une hydratation adéquate peuvent aider à prévenir les troubles." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être recommandés pour les familles à risque." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques peuvent aider à évaluer le risque familial." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles SLC12A4 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations n'ont pas d'impact direct sur SLC12A4." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir les symptômes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un exercice régulier peut contribuer à une meilleure santé globale, mais pas spécifique." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour SLC12A4 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments électrolytiques et des médicaments spécifiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore une option standard." } }, { "@type": "Question", "name": "Les changements alimentaires aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime équilibré peut aider à gérer les déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Des traitements symptomatiques existent-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements symptomatiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec SLC12A4 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles rénaux et des déséquilibres électrolytiques graves." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies associées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies métaboliques peuvent être associées à des anomalies de SLC12A4." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Des soins palliatifs sont-ils nécessaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans les cas graves, des soins palliatifs peuvent être envisagés pour le confort." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour SLC12A4 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux et certaines conditions génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement influence-t-il SLC12A4 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent influencer l'expression de SLC12A4." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut exacerber les problèmes liés à SLC12A4." } }, { "@type": "Question", "name": "Les infections augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent aggraver les symptômes liés à SLC12A4." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut influencer la gravité des symptômes et des complications." } } ] } ] }

Sources (10000 au total)

Comparison of clinical characteristics of testicular tumor between children and adult population: a retrospective analysis.

Testicular tumor (TT) is a uncommon disease posing serious health problem. There are differences in some aspects between adult and pediatric TT. The study was to compare their differences of clinical ... The clinical data of hospitalized patients was collected and analyzed retrospectively from January 2014 to January 2024 at a pediatric and an adult institution, respectively. The data included composi... A total of 195 hospitalized patients were included. There were 135 children and 60 adult with TT, respectively. Of these children, patients were aged from 1 month to 14 years, with a mean age of 2.32 ... The majority of pediatric cases were benign compared to adult. The most common type was prepubertal teratoma and yolk sac tumor. Pediatric TTs often occurred under the age of 1 year. Seminomas and pre...

Postoperative recurrence of mixed extragonadal germ cell tumor in the right shoulder: a case report.

Extragonadal germ cell tumours (EGGCTs) originated in Shoulder are extremely rare, with 1 case described in the literature. We report a case of a patient with a primary Right Shoulder mixed EGGCT.... A 36-year-old male patient was hospitalized for 6 months due to progressive right shoulder swelling accompanied by pain. Subsequently, the right shoulder tumor was removed entirely. Gross pathological... The primary MEGCT of the shoulder is an extremely rare condition. However, the recurrence and metastasis rates are high. Therefore, further research is necessary to determine this rare disease's genet...

[Current view on testicular tumors from a developmental biological perspective : Important biomarkers and molecular pathological investigations].

Germ cell tumors (GCTs) are the most common type of cancer in Germany in young men between 15 and 44 years of age. The routinely performed diagnostic procedures are essential for the patient's treatme... Updated understanding of the molecular processes underlying GCT development and their special forms as well as recommendations for new and useful biomarkers.... The development of GCTs is a dynamic process largely influenced by the microenvironment. Seminomas (SEs) in particular seem to posses a higher cellular plasticity than previously assumed, allowing SEs... The ability of SEs to transit into EC or YSTs should be considered during therapy. Future research should focus on deciphering the special forms GTS and MST as well as the early recognition of YSTs, s...

Primary yolk sac tumor of the endometrium combined with situs inversus totalis: a case report and literature review.

Yolk sac tumor (YST) is a highly malignant germ cell tumor, a majority of which originate from the gonads and are extremely rare from endometrium.... Here we present a case of a 42-year-old woman suffered from primary pure yolk sac tumor of the endometrium complicated with situs inversus totalis. The patient presented at our hospital with irregular... This rare disease needs to be differentiated from endometrial epithelial neoplasia and the significant increase in AFP is helpful for diagnosis. Combined with previous literature reports, comprehensiv...

Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.

Treatment for testicular germ cell tumors (GCTs) includes orchiectomy followed potentially by adjuvant chemotherapy. Rarely, patients with testicular GCT have significant metastatic disease, requiring...

Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.

To evaluate the survival outcomes and establish a risk stratification system in patients with ovarian yolk sac tumors (OYST).... The recurrence-free survival (RFS), disease-specific survival (DSS), and prognostic factors were retrospectively evaluated in 151 OYST patients treated in our hospital between 2006 and 2022. A risk st... The median follow-up time was 5.1 years, with a 5-year RFS and DSS rate of 75.5% and 91.2%, respectively. FIGO stage III-IV and the interval between treatment and normalization of AFP were two prognos... This risk stratification system based on tumor stage and the interval between treatment and normalization of AFP may help to guide clinical management by dividing OYST patients into three risk groups....